Literature DB >> 33988709

Transparency, Accessibility, and Variability of US Hospital Price Data.

Waqas Haque1, Muzzammil Ahmadzada2, Hassan Allahrakha3, Eman Haque4, David Hsiehchen5.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33988709      PMCID: PMC8122228          DOI: 10.1001/jamanetworkopen.2021.10109

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

The United States spends a greater proportion of its gross domestic product on health care than any other nation, which is partly due to the excessive price of goods and services.[1] Price transparency may empower consumers to seek lower-cost care and lead high-cost health care professionals and systems to decrease prices.[2,3,4] The Centers for Medicare & Medicaid Services (CMS) ruling CMS-1694-F, effective on January 1, 2019, mandated that hospital chargemasters be publicly available in a machine-readable file. Herein, we assessed the compliance of hospitals with this CMS ruling 18 months after its effective date.

Methods

This cross-sectional study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. Per the Common Rule, institutional review board approval was not sought because this study is not human participant research. Hospital characteristics were obtained from the CMS website. US hospitals were eligible for inclusion if an institution website was identified. For chargemasters that could not be identified from the institution website, a Google search was performed using the name of the hospital and the terms chargemaster, charge description master, charge list, price list, standard price, or standard charges. To assess the accuracy of a single reviewer assessing chargemaster prevalence, 200 hospitals were reviewed by 2 reviewers (M.A. and E.H.) independently, with 92% agreement (Cohen κ = 0.84), indicating very high concordance. Two undergraduates served as proxies for layperson internet users and reviewed 25 chargemaster items, including common medications and mandatory shoppable services, as defined by CMS.[5] Data abstraction was performed between June 30 and November 20, 2020. Logistic regression analysis was used to determine factors associated with hospital compliance to the CMS ruling. Statistical significance was set at P < .05, and all hypothesis tests were 2-tailed. All statistical analyses were performed using Stata version 16 (StataCorp).

Results

Among the 5288 US hospitals associated with a website, most were located in urban settings (2954 [55.9%]), had fewer than 100 beds (2701 [51.1%]), and were classified as acute care facilities (3255 [61.6%]) (Table). A total of 2723 hospitals (51.5%) did not have an online chargemaster in a machine-readable format, including 305 hospitals (5.8%) with broken links or incorrectly linked files and 138 hospitals (2.6%) that only provided an online cost estimator. The median (interquartile range) number of clicks needed to reach the chargemaster from the institution website homepage was 3 (2-8).
Table.

Factors Associated With Hospital Compliance to the Centers for Medicare & Medicaid Services Price Transparency Rule

Hospital characteristicNo. (%)Univariable analysisMultivariable analysis
OR (95% CI)P valueOR (95% CI)P value
Urban vs rural
Rural2334 (44.1)1 [Reference]NA1 [Reference]NA
Urban2954 (55.9)1.01 (0.90-1.12).901.12 (0.95-1.31).17
Hospital size
Small, <100 beds2701 (51.1)1 [Reference]NA1 [Reference]NA
Medium, 100-300 beds1544 (29.2)1.26 (1.11-1.44)<.0011.06 (0.90-1.26).49
Large, >300 beds1043 (19.7)1.44 (1.23-1.68)<.0011.10 (0.90-1.35).34
Emergency services capable
No847 (16.0)1 [Reference]NA1 [Reference]NA
Yes4440 (84.0)2.38 (2.04-2.79)<.0011.18 (0.95-1.47).13
Patient experience
≥National average4195 (79.3)1 [Reference]NA1 [Reference]NA
<National average1093 (20.7)1.78 (1.55-2.04)<.0011.63 (1.37-1.94)<.001
Hospital type
Acute care3255 (61.6)1 [Reference]NA1 [Reference]NA
Psychiatric582 (11.0)0.36 (0.30-0.44)<.0010.43 (0.33-0.54)<.001
Critical access1355 (25.6)0.75 (0.65-0.85)<.0010.98 (0.81-1.17).79
Children’s96 (1.8)0.57 (0.38-0.86)<.0010.69 (0.45-1.06).09
Hospital ownership
Local government1170 (22.1)1 [Reference]NA1 [Reference]NA
Federal government59 (1.1)0.67 (0.40-1.14).140.69 (0.40-1.18).18
Private nonprofit2624 (49.6)1.16 (1.00-1.34).050.97 (0.84-1.13).73
Religious327 (6.2)0.74 (0.58-0.95).020.56 (0.43-0.73)<.001
Private for-profit1108 (21.0)1.30 (1.09-1.55)<.0011.32 (1.09-1.60)<.001

Abbreviations: NA, not applicable; OR, odds ratio.

Abbreviations: NA, not applicable; OR, odds ratio. In univariable and multivariable regression analyses, below average patient experience (vs at or above average patient experience) and private nonprofit ownership (vs local government ownership) were associated with greater compliance (Table). In contrast, psychiatric hospitals (vs acute care hospitals) and religious ownership (vs local government ownership) were associated with lesser compliance (Table). To assess chargemaster usability, 2 nonmedical reviewers assessed 25 shoppable items in the chargemasters of the 100 largest hospitals by bed number. Across all items, 330 prices (13.2%) were identified by both reviewers, and prices were more frequently identified for medications and laboratory tests than for imaging. Agreement in abstracted prices ranged from 0% to 89% (Figure). Among 22 hospitals with chargemasters including Current Procedural Terminology (CPT) codes, 370 of 551 prices (67.2%) across all 25 items were identified by CPT codes. However, only 21 of 57 prices (36.8%) abstracted by either nonmedical reviewer was concordant with pricing identified using CPT codes.
Figure.

Chargemaster Price Identification and Variation for Shoppable Items Across the 100 Largest US Hospitals

Number of hospitals with matching and nonmatching prices for 25 shoppable items between 2 nonmedical reviewers. CT indicates computed tomography; MRI, magnetic resonance imaging.

Chargemaster Price Identification and Variation for Shoppable Items Across the 100 Largest US Hospitals

Number of hospitals with matching and nonmatching prices for 25 shoppable items between 2 nonmedical reviewers. CT indicates computed tomography; MRI, magnetic resonance imaging.

Discussion

Our study found that most US hospitals remained noncompliant with the CMS-1694-F ruling, and compliance was associated with patient ratings, hospital type, and ownership. Even when publicly accessible, chargemasters were frequently buried within websites and difficult to use accurately. This work calls into question the effectiveness of CMS rulings to promote price transparency and highlights the challenges of creating effective price transparency tools for consumers. Additional data, including negotiated rates mandated in the final rule on price transparency (CMS-1717-F2), may improve the interpretability of hospital prices, but that rule does not address improving access and usability of hospital pricing data.[6] One limitation of this study is that hospital pricing data may not reflect actual charges or costs.
  5 in total

1.  A systemic approach to containing health care spending.

Authors:  Ezekiel Emanuel; Neera Tanden; Stuart Altman; Scott Armstrong; Donald Berwick; François de Brantes; Maura Calsyn; Michael Chernew; John Colmers; David Cutler; Tom Daschle; Paul Egerman; Bob Kocher; Arnold Milstein; Emily Oshima Lee; John D Podesta; Uwe Reinhardt; Meredith Rosenthal; Joshua Sharfstein; Stephen Shortell; Andrew Stern; Peter R Orszag; Topher Spiro
Journal:  N Engl J Med       Date:  2012-08-01       Impact factor: 91.245

2.  What Is the Value of Market-Wide Health Care Price Transparency?

Authors:  Anna D Sinaiko
Journal:  JAMA       Date:  2019-10-15       Impact factor: 56.272

3.  Price transparency for MRIs increased use of less costly providers and triggered provider competition.

Authors:  Sze-jung Wu; Gosia Sylwestrzak; Christiane Shah; Andrea DeVries
Journal:  Health Aff (Millwood)       Date:  2014-08       Impact factor: 6.301

4.  Association Between Availability of a Price Transparency Tool and Outpatient Spending.

Authors:  Sunita Desai; Laura A Hatfield; Andrew L Hicks; Michael E Chernew; Ateev Mehrotra
Journal:  JAMA       Date:  2016-05-03       Impact factor: 56.272

5.  Health Care Spending in the United States and Other High-Income Countries.

Authors:  Irene Papanicolas; Liana R Woskie; Ashish K Jha
Journal:  JAMA       Date:  2018-03-13       Impact factor: 56.272

  5 in total
  2 in total

1.  Adherence to a Federal Hospital Price Transparency Rule and Associated Financial and Marketplace Factors.

Authors:  Waqas Haque; Muzzammil Ahmadzada; Sanjana Janumpally; Eman Haque; Hassan Allahrakha; Sunita Desai; David Hsiehchen
Journal:  JAMA       Date:  2022-06-07       Impact factor: 157.335

2.  Transparency and Variability in Pricing for Pediatric Outpatient Imaging in US Children's Hospitals.

Authors:  Shireen E Hayatghaibi; Vinicius V Alves; Rama S Ayyala; Jonathan R Dillman; Andrew T Trout
Journal:  JAMA Netw Open       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.